MRI

Latest News


CME Content


Could Gamification Enhance Brain MRI Acquisition?

FIRMM-pix, a brain magnetic resonance imaging (MRI) software module recently launched at the International Society for Magnetic Resonance in Medicine (ISMRM) conference, reportedly employs visual biofeedback and gamification that coaches patients to stay still during brain MRI exams.

Stress Cardiovascular MRI: What a New Meta-Analysis Reveals

For the detection of obstructive coronary artery disease (CAD), stress cardiovascular magnetic resonance imaging (MRI) demonstrated a sensitivity rate of 81 percent and a specificity rate of 86 percent, according to a meta-analysis of 64 studies and data from 74,470 patients with stable chest pain.

MRI Findings Show Vorasidenib More Than Doubles Progression-Free Survival in Patients with Grade 2 IDH Gliomas

For patients with residual or recurrent grade 2 isocitrate dehydrogenase (IDH)-mutant gliomas, magnetic resonance imaging (MRI) revealed that daily dosing of vorasidenib, an inhibitor of mutant IDH1 and IDH2 enzymes, led to a median progression-free survival of 27.7 months in comparison to 11.1 months in a placebo group, according to new research presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Can Abbreviated MRI Have an Impact in Neuroimaging?

In a recently published review, radiology researchers from the University of Wisconsin discussed the potential and key considerations for applying accelerated magnetic resonance imaging (MRI) protocols in the assessment of emergent and urgent conditions.

In a recent video interview, David Ouyang, M.D., shared insights from two recent studies he co-authored on the use of artificial intelligence (AI) to improve initial assessment of left ventricular ejection fraction (LVEF) on echocardiography and ascertain cardiac risks associated with changes in the left ventricle sphericity index seen on magnetic resonance imaging (MRI).

New ACR Guidelines Emphasize Earlier Breast Cancer Screening for High-Risk Women

While calling for a universal breast cancer risk assessment by the age of 25, the American College of Radiology (ACR) emphasized that ascertaining screening needs prior to the age of 40 is particularly important in high-risk populations such as Black women, who are 42 percent more likely to die from breast cancer in comparison to non-Hispanic White women.

TeraRecon Launches AI-Powered Neuro Suite

The artificial intelligence (AI)-powered Neuro Suite reportedly enables radiologists to access leading neurological AI algorithm solutions in the field, including the brain magnetic resonance imaging (MRI) segmentation capabilities of the Combinostics’ algorithm that can help differentiate degenerative pathologies such as Alzheimer’s disease and dementia.